Background and Aim: The aim of this retrospective study was to examine the relationship between diabetes mellitus and recurrence of hepatocellular carcinoma after potentially curative therapy for ...

Diabetes mellitus (DM) appears to be an independent predictor of disease recurrence and progression among patients with non-muscle invasive bladder cancer (NMIBC), according to investigators. In a ...

Hepatocellular carcinoma, a type of liver cancer associated with hepatitis infections, is known to have a high recurrence rate after cancer removal. Recent advances in antiviral therapy have reduced ...

Following ablation for AF, GLP-1 agonist therapy is associated with decreased risk for AF recurrence in patients with type 2 diabetes. Glucagon-like peptide-1 receptor (GLP-1) agonist use is ...

Patients with differentiated thyroid cancer treated with the GLP-1s showed no increased risk of recurrence over a more than 5-year follow-up.